Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5176455
Max Phase: Preclinical
Molecular Formula: C46H66N14O15S2
Molecular Weight: 1119.25
Associated Items:
ID: ALA5176455
Max Phase: Preclinical
Molecular Formula: C46H66N14O15S2
Molecular Weight: 1119.25
Associated Items:
Canonical SMILES: C[C@@H](O)[C@@H]1NC(=O)[C@@H](NC(=O)CN)CSCC(=O)CSC[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC1=O
Standard InChI: InChI=1S/C46H66N14O15S2/c1-22(61)37-43(72)55-27(8-4-12-51-46(49)50)38(67)54-28(10-11-34(48)63)39(68)56-29(14-23-17-52-26-7-3-2-6-25(23)26)44(73)60-13-5-9-33(60)42(71)58-32(40(69)57-30(45(74)75)15-36(65)66)21-77-19-24(62)18-76-20-31(41(70)59-37)53-35(64)16-47/h2-3,6-7,17,22,27-33,37,52,61H,4-5,8-16,18-21,47H2,1H3,(H2,48,63)(H,53,64)(H,54,67)(H,55,72)(H,56,68)(H,57,69)(H,58,71)(H,59,70)(H,65,66)(H,74,75)(H4,49,50,51)/t22-,27+,28+,29+,30+,31+,32+,33+,37+/m1/s1
Standard InChI Key: NOAZFYPTTNESLA-WLLRZNNESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1119.25 | Molecular Weight (Monoisotopic): 1118.4273 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Gonschorek P, Zorzi A, Maric T, Le Jeune M, Schüttel M, Montagnon M, Gómez-Ojea R, Vollmar DP, Whitfield C, Reymond L, Carle V, Verma H, Schilling O, Hovnanian A, Heinis C.. (2022) Phage Display Selected Cyclic Peptide Inhibitors of Kallikrein-Related Peptidases 5 and 7 and Their In Vivo Delivery to the Skin., 65 (14.0): [PMID:35653695] [10.1021/acs.jmedchem.2c00306] |
Source(1):